Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

India Globalization Capital Gets Listing Deficiency Letter From NYSE MKT

India Globalization Capital Inc. (IGC: Quote) announced that on December 11, 2012, it received a notice from the NYSE MKT LLC stating that the company is not in compliance with Section 1003(f)(iv) of the Exchange's Company Guide.

Specifically the Exchange Staff has determined that the Company has not paid the outstanding listing fees balance for a substantial period of time and, pursuant to Section 1003(f)(iv) of the Company guide, the Company's continued listing is predicated on it submitting all unpaid listing fees due to the Exchange by January 10, 2013.

Click here to receive FREE breaking news email alerts for India Globalization Capital Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks have moved mostly higher over the course of the trading day on Monday, extending the strong upward move that was seen last Friday. The major averages are currently turning in a mixed performance, however, with a steep drop by shares of IBM (IBM) weighing on the Dow. While Republicans have largely tried to frame the upcoming midterm elections as a referendum on President Barack Obama, Sen. Ted Cruz, R-Tex., has joined the few offering guidance on what the GOP will do if it manages to retake control of the Senate. The World Health Organization (WHO) Monday declared that Nigeria is officially free of Ebola virus transmission. For the last six weeks, no new cases of the deadly virus infection has been reported in the country. The lines on the tabular situation reports, sent to WHO each day by its country office in Nigeria, have now been full of zeros for 42 days. If two incubation periods of 21 days pass
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.